MEDICUS PHARMA LTD. Repayments of Debt
MEDICUS PHARMA LTD. (MDCX) reported Repayments of Debt of $5.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2026-08-12
- MEDICUS PHARMA LTD. repayments of debt for the quarter ending 2026-06-30 was $2.35M.
- MEDICUS PHARMA LTD. repayments of debt for the quarter ending 2026-03-31 was $3.18M.
- MEDICUS PHARMA LTD. repayments of debt for the quarter ending 2025-12-31 was $1.75M.
- MEDICUS PHARMA LTD. repayments of debt for the quarter ending 2025-09-30 was $5.64M.
- MEDICUS PHARMA LTD. repayments of debt for fiscal 2025 was $7.39M.
- MEDICUS PHARMA LTD. repayments of debt for fiscal 2024 was $0.00.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $5.53M 10-Q · filed 2026-08-12 | $7.29M derived: sum of 3 quarters · filed 2026-08-12 | $12.92M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $3.18M 10-Q · filed 2026-05-14 | $4.94M derived: sum of 2 quarters · filed 2026-05-14 | $10.58M derived: sum of 3 quarters · filed 2026-05-14 | $10.58M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $7.39M derived: sum of 2 quarters · filed 2026-03-25 | $7.39M derived: sum of 3 quarters · filed 2026-08-12 | $7.39M 10-K · filed 2026-03-25 |
| 2025-09-30 | $5.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $5.64M derived: sum of 2 quarters · filed 2026-08-12 | $5.64M 10-Q · filed 2025-11-14 | $5.64M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |